Cambridge Investment Research Advisors’s Vericel Corp VCEL Stock Holding History
Bought
Maintained
Sold
Other funds holding VCEL
BCM
CCA
CAM
GKIM
Cambridge Investment Research Advisors's VCEL Position: Q3 2024 in Review
Cambridge Investment Research Advisors sold out of Vericel Corp (VCEL) in Q3 2024, closing a stake of 4,383 shares — an estimated $201K sold.
Cambridge Investment Research Advisors first reported a position in VCEL in Q1 2019 and held it in 22 quarters. The position peaked at $1.19M in Q1 2021. 268 funds tracked by Wall St. Rank hold VCEL as of Q3 2024.
- Cambridge Investment Research Advisors reported no remaining Vericel Corp position as of Q3 2024 after selling out during the quarter.
- Cambridge Investment Research Advisors sold 4,383 Vericel Corp shares in Q3 2024, an estimated $201K.
- Cambridge Investment Research Advisors first reported a position in Vericel Corp in Q1 2019 and held it in 22 quarters.
- Cambridge Investment Research Advisors's Vericel Corp position peaked at $1.19M in Q1 2021.
- 268 funds tracked by Wall St. Rank held Vericel Corp as of Q3 2024.
Based on Cambridge Investment Research Advisors's 13F filing for Q3 2024, filed 28 Oct 2024.